0.745
0.00 (0.00%)
| Penutupan Terdahulu | 0.745 |
| Buka | 0.750 |
| Jumlah Dagangan | 129,070 |
| Purata Dagangan (3B) | 394,584 |
| Modal Pasaran | 256,950,496 |
| Harga / Pendapatan (P/E Ke hadapan) | 40.32 |
| Harga / Jualan (P/S) | 3.74 |
| Harga / Buku (P/B) | 3.15 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 26 Nov 2024 |
| Margin Keuntungan | -15.39% |
| Margin Operasi (TTM) | -13.37% |
| EPS Cair (TTM) | -0.020 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 9.30% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 7.83% |
| Nisbah Semasa (MRQ) | 7.26 |
| Aliran Tunai Operasi (OCF TTM) | -7.38 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -11.84 M |
| Pulangan Atas Aset (ROA TTM) | -5.86% |
| Pulangan Atas Ekuiti (ROE TTM) | -10.80% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (AU) | Bercampur | Bercampur |
| Medical Devices (Global) | Bercampur | Bercampur | |
| Stok | AROA BIO FPO [ARX] | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -5.0 |
| Purata Bergerak Teknikal | 1.5 |
| Osilator Teknikal | 4.0 |
| Purata | 0.13 |
|
Aroa Biosurgery Ltd is a soft tissue regeneration company which develops, manufactures and sells medical devices for wound and soft tissue repair using its proprietary extracellular matrix (ECM) technology. It is focused on improving the rate and quality of healing in complex wounds and soft tissue reconstruction. The Company is in the business of developing, manufacturing and selling soft tissue repair products. The company's principal market is the United States where it has five key products for sale targeting chronic wounds, hernia, plastics, reconstructive surgery and trauma/limb salvage/tumor surgery. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 26.29% |
| % Dimiliki oleh Institusi | 21.72% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |